Protagonist Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 144.85 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 9.37B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class or...